Fidelity Investments’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,122,861
| Closed | -$32.9M | – | 2756 |
|
|
2017
Q3 | $32.9M | Sell |
1,122,861
-21,330
| -2% | -$597K | ﹤0.01% | 1509 |
|
|
2017
Q2 | $30M | Sell |
1,144,191
-843,732
| -42% | -$20.7M | ﹤0.01% | 1512 |
|
|
2017
Q1 | $46.5M | Sell |
1,987,923
-302,395
| -13% | -$7.46M | 0.01% | 1330 |
|
|
2016
Q4 | $57.6M | Sell |
2,290,318
-320,114
| -12% | -$8.08M | 0.01% | 1227 |
|
|
2016
Q3 | $73.3M | Buy |
2,610,432
+163,545
| +7% | +$4.19M | 0.01% | 1132 |
|
|
2016
Q2 | $60.3M | Buy |
2,446,887
+1,489,361
| +156% | +$37M | 0.01% | 1190 |
|
|
2016
Q1 | $21.2M | Buy |
957,526
+513,071
| +115% | +$13.7M | ﹤0.01% | 1635 |
|
|
2015
Q4 | $15.6M | Buy |
444,455
+60,915
| +16% | +$1.91M | ﹤0.01% | 1797 |
|
|
2015
Q3 | $10.9M | Buy |
383,540
+39,300
| +11% | +$1.32M | ﹤0.01% | 1917 |
|
|
2015
Q2 | $11.5M | Buy |
344,240
+15,900
| +5% | +$488K | ﹤0.01% | 1956 |
|
|
2015
Q1 | $9.26M | Buy |
328,340
+45,800
| +16% | +$1.14M | ﹤0.01% | 2026 |
|
|
2014
Q4 | $5.85M | Sell |
282,540
-871,465
| -76% | -$20.7M | ﹤0.01% | 2173 |
|
|
2014
Q3 | $28.2M | Buy |
1,154,005
+270,671
| +31% | +$7.18M | ﹤0.01% | 1584 |
|
|
2014
Q2 | $25.3M | Sell |
883,334
-388,535
| -31% | -$10.8M | ﹤0.01% | 1680 |
|
|
2014
Q1 | $35.6M | Buy |
1,271,869
+386,437
| +44% | +$9.49M | ﹤0.01% | 1481 |
|
|
2013
Q4 | $19M | Buy |
885,432
+871,758
| +6,375% | +$15.8M | ﹤0.01% | 1732 |
|
|
2013
Q3 | $181K | Sell |
13,674
-118,896
| -90% | -$1.6M | ﹤0.01% | 2579 |
|
|
2013
Q2 | $1.84M | Buy |
+132,570
| New | +$1.88M | ﹤0.01% | 2324 |
|
Fidelity Investments's PMC Position: Q4 2017 in Review
Fidelity Investments sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 1,122,861 shares — an estimated $32.9M sold.
Fidelity Investments first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $73.3M in Q3 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Fidelity Investments reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Fidelity Investments sold 1,122,861 PharMerica Corporation shares in Q4 2017, an estimated $32.9M.
- Fidelity Investments first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Fidelity Investments's PharMerica Corporation position peaked at $73.3M in Q3 2016.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.